Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TPST

Tempest Therapeutics (TPST) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $0.76 -1.3% on the day -92.9% over 12 months 52-week range $0.76 – $11.83

Share price and insider trades

TPST closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $1,000,002 on 2026-03-24 · Matthew Angel
Bought, 12 months$1.0M
Sold, 12 months$0
Insiders buying1
Insiders selling0

Tempest Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $1.0M and 0 sold $0 of TPST stock on the open market.

TPST insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $1.0M bought (2 trades)$1.0MQ1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026$1.0M2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.1×Last 5 sessions
Insiders' paper profit−$648KOn all tracked purchases -64.8%

Summary

Over the past 12 months, 1 Tempest Therapeutics, Inc. insider reported open-market purchases totaling $1.0M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Matthew Angel (CEO, President) has the highest Insider Score at 6.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 23SEC Matthew AngelCEO, President Buy 231,482new position $2.16 $500K -64.8% 6
Mar 25SEC Matthew AngelCEO, President Buy 231,482new position $2.16 $500K -64.8% 6

Insiders at Tempest Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Matthew AngelCEO, President $1.0M — Jun 23, 2026 6

TPST stock: common questions

Are Tempest Therapeutics, Inc. insiders buying TPST stock?

In the past 12 months, 1 insiders reported open-market purchases of TPST worth $1.0M. The latest was CEO, President Matthew Angel bought $500K of TPST at $2.16 — first open-market purchase in our records; opens a new position.

Are Tempest Therapeutics, Inc. insiders selling TPST stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TPST's 52-week range?

Over the past year TPST has traded between $0.76 and $11.83. It last closed at $0.76 on Oct 9, 2026.